drugset / Trial / NCT01675297
Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With Osteoporosis
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and the safety of Risedronate, cholecalciferol combination tablet in patients with Osteoporosis.
Timeline
- Start
- 2011-07-04
- Primary completion
- 2013-12
- Completion
- 2014-04-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cholecalciferol | Other / unclassified | — | — |
| Comparator | Risedronate | Small molecule | 35 mg | — |